Vaginal DHEA Cream for Women: How Local Hormone Biology Supports Midlife Tissue Health

Vaginal tissues retain the ability to synthesize small amounts of sex hormones locally from circulating precursors such as dehydroepiandrosterone (DHEA). This process—known as intracrine hormone synthesis—allows vulvovaginal cells to convert DHEA into estrogens and androgens within the tissue itself, even after menopause.  

Why Vaginal Tissue Can Produce Hormones Locally

Unlike many other tissues, vulvovaginal epithelial and stromal cells contain enzymes capable of converting circulating steroid precursors into active sex hormones locally. DHEA can be converted into both estrogens and androgens through enzymatic pathways including 3β-hydroxysteroid dehydrogenase, 17β-hydroxysteroid dehydrogenase, aromatase, and related steroidogenic enzymes expressed in peripheral tissues (Labrie et al., 2003; Labrie 2019).

Because these conversions occur within the same cells that utilize the hormones, the resulting estrogens and androgens act locally rather than circulating systemically. This biological mechanism—termed intracrinology—allows tissues to regulate their own hormone exposure while maintaining low systemic hormone concentrations (Labrie 1991; Labrie 2019).

What Happens to Vulvovaginal Tissue in Midlife

During the menopausal transition, declining ovarian hormone production alters the biological environment of vulvovaginal tissue. Reduced estrogen and androgen signaling affects epithelial turnover, extracellular matrix composition, vascular responsiveness, and mucosal hydration.

Over time, these changes may influence lubrication, elasticity, and sensory responsiveness within vulvar and vaginal tissues and are collectively described clinically as genitourinary syndrome of menopause (GSM) (Portman & Gass 2014).

Vulvovaginal atrophy and related tissue changes can affect epithelial maturation, connective-tissue architecture, and sexual comfort in postmenopausal women (Kingsberg et al. 2013; Nappi & Palacios 2014).

How Vaginal DHEA Works

Vaginally delivered DHEA provides a local precursor substrate that can be converted within vulvovaginal tissue into small amounts of estrogens and androgens through intracrine enzymatic pathways.

Because these conversions occur primarily within the tissue itself, circulating hormone levels generally remain within postmenopausal ranges in clinical studies of intravaginal DHEA formulations (Archer et al., 2015; Labrie et al., 2018).

This tissue-level hormone production may support epithelial maturation, lubrication, and tissue physiology while maintaining minimal systemic hormone exposure.

Evidence From Clinical Studies

Clinical trials investigating intravaginal DHEA formulations have reported improvements in measures of vaginal epithelial maturation, tissue structure, and sexual comfort among postmenopausal women (Archer et al., 2015; Labrie et al., 2016; Labrie et al., 2018).

These studies support the concept that local steroid precursor availability can influence vulvovaginal tissue biology through intracrine pathways, allowing peripheral tissues to generate small amounts of active hormones within the tissue itself.

Why Local Biology Matters

Vulvovaginal health is regulated by a complex interaction between epithelial turnover, connective tissue architecture, vascular dynamics, and sensory nerve function.

Because these systems depend on local signaling environments rather than circulating hormone levels alone, biological support strategies increasingly focus on tissue-level physiology rather than systemic endocrine replacement (Kingsberg et al. 2013; Nappi & Palacios 2014).

Biological Support for the Midlife Vulva

The Vulva Co develops formulations designed to support the evolving biology of midlife vulvovaginal tissue. Rather than attempting to override natural physiology, these approaches aim to support the local biological processes that maintain tissue comfort, hydration, and responsiveness.

 

FAQ Section

What is vaginal DHEA?

Vaginal DHEA is a steroid precursor applied locally to vulvovaginal tissue. Within the tissue, enzymes can convert DHEA into small amounts of estrogen and androgen hormones through intracrine pathways.

Does vaginal DHEA increase hormone levels in the blood?

Clinical studies of intravaginal DHEA formulations generally show minimal changes in circulating hormone levels, suggesting that hormone conversion occurs primarily within the local tissue environment.

Why do vaginal tissues still respond after menopause?

Vulvovaginal tissues maintain the enzymatic machinery required for intracrine hormone synthesis even after ovarian hormone production declines.

References

Labrie F. Intracrinology.
Molecular and Cellular Endocrinology. 1991.
https://pubmed.ncbi.nlm.nih.gov/1838082/

Labrie F. Intracrinology and menopause: the role of DHEA in the formation of estrogens and androgens.
Menopause. 2019.
https://pubmed.ncbi.nlm.nih.gov/30130283/

Archer DF, Labrie F, Bouchard C, et al.
Treatment of dyspareunia with intravaginal dehydroepiandrosterone (prasterone).
Menopause. 2015.
https://pubmed.ncbi.nlm.nih.gov/26035204/

Labrie F, Archer DF, Koltun W, et al.
Efficacy of intravaginal dehydroepiandrosterone on dyspareunia and vaginal dryness in postmenopausal women.
Menopause. 2016.
https://pubmed.ncbi.nlm.nih.gov/26731686/

Labrie F, Archer DF, Koltun W, et al.
Intravaginal dehydroepiandrosterone improves vaginal tissue structure and function.
Menopause. 2018.
https://pubmed.ncbi.nlm.nih.gov/29474244/

Portman DJ, Gass MLS.
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy.
Menopause. 2014.
https://pubmed.ncbi.nlm.nih.gov/25160739/

Kingsberg SA, Wysocki S, Magnus L, Krychman ML.
Vulvar and vaginal atrophy in postmenopausal women.
Journal of Sexual Medicine. 2013.
https://pubmed.ncbi.nlm.nih.gov/23445174/

Nappi RE, Palacios S.
Impact of vulvovaginal atrophy on sexual health.
Climacteric. 2014.
https://pubmed.ncbi.nlm.nih.gov/24601899/

Labrie F, Luu-The V, Labrie C, et al.
Expression of steroidogenic enzymes in peripheral tissues.
Journal of Steroid Biochemistry and Molecular Biology. 2003.
https://pubmed.ncbi.nlm.nih.gov/14623514/

 

Author: Dr. Laura Kelly
Natural medicine physician and researcher in precision women’s health. Editor of The Implementation of Personalized Precision Medicine (Elsevier Academic Press, 2024).